Ad
related to: moderna covid-19 vaccine progress
Search results
Moderna slips after the COVID vaccine maker cuts 2022 sales guidance and misses 3rd quarter...
Business Insider via Yahoo Finance· 2 years agoAdministering Moderna's Covid-19 vaccine in London.Dinendra Haria/SOPA Images/LightRocket via Getty...
Merck, Moderna detail potential skin cancer vaccine progress
Associated Press via Yahoo News· 1 year agoModerna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a...
Can Moderna (MRNA) Diversify Beyond Its COVID-19 Jab Sales?
Zacks via Yahoo Finance· 9 months agoWith COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its...
Vaccines Helped to Control COVID-19. But the Global Rollout Is Still Broken
Time via Yahoo News· 1 year agoA Kenyan health worker receives a dose of the Oxford/AstraZeneca vaccine, part of the COVAX...
Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial
Press Association News via AOL· 1 year agoA High Court battle between rival developers of Covid-19 jabs over patents for vaccine technology is...
Moderna's mRNA-Based RSV Vaccine Just Passed a Major Test
Time via Yahoo News· 1 year agoCredit - Getty Images/Cavan Images RF Moderna has become a well-known name thanks to its highly...
Moderna tops 1Q forecasts; vaccine sales plunge as expected
Associated Press via Yahoo News· 1 year agoSales of Moderna’s COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall...
Can Moderna's (MRNA) Launches Reduce COVID Sales Dependency?
Zacks via Yahoo Finance· 4 months agoWith COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its...
Moderna stock plunges following mixed analyst reviews of cancer vaccine data
Yahoo Finance· 1 year agoModerna's (MRNA) stock dropped Monday despite positive news over the weekend from a Phase 2 trial of...
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) knows that it needs new products. The good news is that Moderna has three...
